BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kondo T, Oshima T, Tomita T, Fukui H, Okada H, Watari J, Miwa H. The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers. Clin Gastroenterol Hepatol 2015;13:1249-1255.e1. [PMID: 25632805 DOI: 10.1016/j.cgh.2015.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Sadatomi D, Kono T, Mogami S, Fujitsuka N. Weak acids induce PGE2 production in human oesophageal cells: novel mechanisms underlying GERD symptoms. Sci Rep 2020;10:20775. [PMID: 33247192 DOI: 10.1038/s41598-020-77495-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Bai X, Ihara E, Otsuka Y, Tsuruta S, Hirano K, Tanaka Y, Ogino H, Hirano M, Chinen T, Akiho H, Nakamura K, Oda Y, Ogawa Y. Involvement of different receptor subtypes in prostaglandin E2-induced contraction and relaxation in the lower esophageal sphincter and esophageal body. Eur J Pharmacol 2019;857:172405. [PMID: 31128092 DOI: 10.1016/j.ejphar.2019.172405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Johnston BT. Oesophageal dysphagia: a stepwise approach to diagnosis and management. Lancet Gastroenterol Hepatol 2017;2:604-9. [PMID: 28691686 DOI: 10.1016/S2468-1253(17)30001-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
4 Menezes MA, Herbella FAM. Pathophysiology of Gastroesophageal Reflux Disease. World J Surg. 2017;41:1666-1671. [PMID: 28258452 DOI: 10.1007/s00268-017-3952-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
5 Miwa H, Kondo T, Oshima T. Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment. Curr Opin Gastroenterol 2016;32:344-52. [PMID: 27206157 DOI: 10.1097/MOG.0000000000000282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kondo T, Miwa H. The Role of Esophageal Hypersensitivity in Functional Heartburn. Journal of Clinical Gastroenterology 2017;51:571-8. [DOI: 10.1097/mcg.0000000000000885] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
7 Kondo T, Sei H, Yamasaki T, Tomita T, Ohda Y, Oshima T, Fukui H, Watari J, Miwa H. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol 2017;52:1081-9. [DOI: 10.1007/s00535-017-1308-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Sei H, Oshima T, Shan J, Wu L, Yamasaki T, Okugawa T, Kondo T, Tomita T, Fukui H, Watari J, Miwa H. Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn. PLoS One 2016;11:e0154234. [PMID: 27111066 DOI: 10.1371/journal.pone.0154234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]